Pfizer is a "dog with fleas" due to poor sales and earnings growth, making it uninteresting.
Source Post
Pfizer Earnings Preview: Still a Dog Stock After COVID?
Navellier Market Buzz with Louis NavellierMay 4, 2026
Louis Navellier expresses a negative outlook on Pfizer, calling it a "dog with fleas" due to stagnant sales growth and declining earnings. He is not interested in the stock despite potential for positive surprises.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.